Mitochondrial replacement has not yet been described in any BTN, so further analysis will be required to determine the full recombinant cancer mitogenomes and to test whether there is any selective advantage of this recombinant mitogenome in Mytilus BTN2. The gene discussed is BTN1A1; the disease is cancer.